- Hematology in Clinical Practice
- Search Author Details
Author Details
Jamroziak, Krzysztof
-
Vol 2, No 3 (2011) - REVIEW ARTICLE
Role of maintenance therapy in the treatment of plasma cell myeloma
Abstract PDF (Polish) -
Vol 2, No 2 (2011) - REVIEW ARTICLE
Therapy of relapsed and refractory plasma cell myeloma
Abstract PDF (Polish) -
Vol 4, No 4 (2013) - REVIEW ARTICLE
Plasma cell myeloma — management recommendation of the Institute of Hematology and Transfusion Medicine
Abstract PDF (Polish) HTML (Polish) -
Vol 6, No 1 (2015) - REVIEW ARTICLE
Advances in diagnosis and treatment of patients with plasma cell myeloma
Abstract PDF (Polish) HTML (Polish) -
Vol 6, No 3 (2015) - REVIEW ARTICLE
The etiology and pathogenesis of plasma cell myeloma
Abstract PDF (Polish) HTML (Polish) -
Vol 7, No 3 (2016) - REVIEW ARTICLE
The role of idelalisib in the treatment of patients with chronic lymphocytic leukemia
Abstract PDF (Polish) -
Vol 8, No 1 (2017) - REVIEW ARTICLE
The role of venetoclax in the treatment of patients with chronic lymphocytic leukemia
Abstract PDF (Polish) HTML (Polish) -
Vol 8, No 4 (2017) - REVIEW ARTICLE
The role of daratumumab in the treatment of patients with relapsed/refractory plasma cell myeloma
Abstract PDF (Polish) -
Vol 8, No 4 (2017) - ORIGINAL ARTICLE
Minimal residual disease assessment in plasma cell myeloma patients in Poland: survey of the Polish Myeloma Consortium
Abstract PDF (Polish) -
Vol 8, No 4 (2017) - REVIEW ARTICLE
Current role of minimal residual disease in plasma cell myeloma: Position of Polish Myeloma Consortium
Abstract PDF (Polish) -
Vol 9, No 3 (2018) - REVIEW ARTICLE
Principles of amyloidosis classification and nomenclature
Abstract PDF (Polish) -
Vol 9, No 3 (2018) - CASE REPORT
How we treat a patient with intermediate-risk light chain amyloidosis? The role of doxycycline in cardiac amyloidosis.
Abstract PDF (Polish) -
Vol 9, No 3 (2018) - REVIEW ARTICLE
Diagnostics and treatment of AL amyloidosis
Abstract PDF (Polish) -
Vol 9, No 3 (2018) - REVIEW ARTICLE
Doxycycline in the treatment of systemic amyloidosis with cardiac involvement.
Abstract PDF (Polish) -
Vol 10, No 1 (2019) - ORIGINAL ARTICLE
Benefit/risk profile of idelalisib treatment in patients with chronic lymphocytic leukemia and non-Hodgkin lymphoma
Abstract PDF -
Vol 13, No 1 (2022) - REVIEW ARTICLE
IGHV mutational status and the choice of first-line therapy for patients with chronic lymphocytic leukaemia
Abstract PDF
Important: This website uses cookies. More >>
The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.
By VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
phone:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl